Apotex Seeks To Revive Hospira Unfair Competition Fight
Apotex Corp. is asking the Second Circuit to step in and save its suit accusing Hospira of unfair competition by reneging on a promise to keep supplying Apotex with a generic...To view the full article, register now.
Already a subscriber? Click here to view full article